Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s stock price traded down 3.1% on Monday . The company traded as low as $44.28 and last traded at $46.33. 3,093,174 shares changed hands during mid-day trading, a decline of 41% from the average session volume of 5,233,347 shares. The stock had previously closed at $47.83.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on the stock. Wolfe Research lowered shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Guggenheim restated a "buy" rating on shares of Tempus AI in a report on Tuesday, February 25th. Needham & Company LLC upped their price objective on shares of Tempus AI from $56.00 to $70.00 and gave the company a "buy" rating in a research note on Tuesday, February 25th. Bank of America lifted their target price on shares of Tempus AI from $54.00 to $60.00 and gave the company a "neutral" rating in a research note on Monday, March 3rd. Finally, Loop Capital dropped their price target on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating on the stock in a research note on Tuesday, January 14th. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, Tempus AI has an average rating of "Moderate Buy" and a consensus price target of $61.18.
Get Our Latest Stock Report on Tempus AI
Tempus AI Trading Down 7.5 %
The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The firm's fifty day moving average is $58.62 and its 200 day moving average is $51.55.
Insider Transactions at Tempus AI
In related news, major shareholder Bradley A. Keywell sold 170,720 shares of the business's stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $35.45, for a total transaction of $6,052,024.00. Following the transaction, the insider now owns 15,993,729 shares of the company's stock, valued at approximately $566,977,693.05. The trade was a 1.06 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Wayne A.I. Frederick sold 3,000 shares of the stock in a transaction on Monday, March 31st. The shares were sold at an average price of $45.54, for a total transaction of $136,620.00. Following the completion of the sale, the director now directly owns 26,514 shares of the company's stock, valued at approximately $1,207,447.56. This trade represents a 10.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 5,601,969 shares of company stock worth $317,330,782.
Institutional Investors Weigh In On Tempus AI
A number of institutional investors have recently added to or reduced their stakes in the company. ARK Investment Management LLC lifted its position in shares of Tempus AI by 132.1% in the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock worth $186,343,000 after acquiring an additional 3,141,487 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its position in Tempus AI by 166.0% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after purchasing an additional 2,021,394 shares during the period. Nikko Asset Management Americas Inc. boosted its stake in Tempus AI by 166.0% during the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after buying an additional 2,021,394 shares in the last quarter. Franklin Resources Inc. increased its holdings in Tempus AI by 240.5% in the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock valued at $93,251,000 after buying an additional 1,950,862 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in shares of Tempus AI by 86,947.2% in the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock valued at $55,836,000 after buying an additional 1,651,996 shares in the last quarter. 24.22% of the stock is owned by institutional investors and hedge funds.
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
